The final text of the chapter has been published and will become official in May 2025

What does this mean to you?

Attend this virtual meeting and hear from Eli Lilly and AstraZeneca on their approaches
PLUS
To move or not to move? Hear presentations from several endotoxin companies who will provide an overview of their technology that meets USP<86> and, what is covered in their supplier validation packages to help you make that informed choice.

Click here for more information and to register.

Read the rapidmicrobiology special focus on Moving to Sustainable Endotoxin Testing which includes 3 expert insight interviews.